NCI | Technology Transfer

DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS

Read more about DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS

Japan
2000-533395
Filed on 1999-02-24

DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS

Read more about DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS

European Patent
99910987.9
Filed on 1999-02-24

G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS

Read more about G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS

Canada
2321962
Filed on 1999-02-26

ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS)

Read more about ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS)

Canada
2317942
Filed on 1999-01-15

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Japan
2000-516030
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

European Patent
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Canada
2308127
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Australia
95004/98
Filed on 1998-09-22

NOVEL HUMAN CANCER ANTIGEN NY ESO-1/CAG-3 AND GENE ENCODING SAME

Read more about NOVEL HUMAN CANCER ANTIGEN NY ESO-1/CAG-3 AND GENE ENCODING SAME

European Patent
98949385.3
Filed on 1998-09-21

ANTITUMOR MACROCYCLIC LACTONES, COMPOSITIONS AND METHODS OF USE

Read more about ANTITUMOR MACROCYCLIC LACTONES, COMPOSITIONS AND METHODS OF USE

Australia
85015/98
Filed on 1998-07-23

Subscribe to NCI